A detailed history of Everest Management Corp. transactions in Eli Lilly & CO stock. As of the latest transaction made, Everest Management Corp. holds 378 shares of LLY stock, worth $319,134. This represents 0.26% of its overall portfolio holdings.

Number of Shares
378
Holding current value
$319,134
% of portfolio
0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $274,881 - $352,318
378 New
378 $292 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $802B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Everest Management Corp. Portfolio

Follow Everest Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everest Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on Everest Management Corp. with notifications on news.